# Antisepsis Regimen in the Surgical Treatment of Human Papilloma Virus Generated Cervical Lesions: Polyhexamethylene Biguanide Versus Chlorhexidine

> **NCT01740245** · PHASE4 · COMPLETED · sponsor: **AGUNCO Obstetrics and Gynecology Centre**

## Conditions studied

- Antisepsis Regimen After Surgical Treatment of HPV Infected Lesions

## Interventions

- **DEVICE:** Chlorhexidine vaginal suppositories
- **DEVICE:** Polyhexamethylene biguanide vaginal suppositories

## Key facts

- **NCT ID:** NCT01740245
- **Lead sponsor:** AGUNCO Obstetrics and Gynecology Centre
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2012-12-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01740245

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01740245, "Antisepsis Regimen in the Surgical Treatment of Human Papilloma Virus Generated Cervical Lesions: Polyhexamethylene Biguanide Versus Chlorhexidine". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01740245. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*